Thyroid disorder decisions — 2025

The Board granted service connection for prostate cancer residuals, Parkinson's disease, ischemic heart disease, hypothyroidism, peripheral neuropathy, and testicular disability on a basis other than the PACT Act.

The Board remands all claims for further examination and medical opinion to determine the etiology of the Veteran's conditions.

The Board remands the claim for service connection for hypothyroidism to obtain a medical opinion regarding the etiology of the condition, as the Veteran reported exposure to herbicide agents during military service.

The Board remands the claims for an increased rating in excess of 10 percent for multinodular goiter with intermittent hyperthyroidism and syncopal episodes associated with paroxysmal atrial fibrillation, and in excess of 20 percent for femoral neuropathy, left leg, due to a lack of substantial compliance with the previous remand instructions.

The Board remands the claims for service connection for kidney and thyroid cancer to obtain additional medical opinions regarding their etiology, specifically addressing the Veteran's exposure to herbicide agents during service.

The Board remands the issues of service connection for thyroid cancer and an initial rating greater than 30 percent for chronic kidney disease, stage 3 due to incomplete evidence.

The Board denied an earlier effective date for the grant of service connection for onychomycosis and hypothyroidism.

The Board denied service connection for Parkinson's disease and hypothyroidism, as well as a total disability rating based on individual unemployability (TDIU), due to the lack of evidence linking these conditions to the Veteran's military service.

The Board granted service connection for a thyroid disability, to include hypothyroidism and euthyroid multinodular goiter with an enlarged gland as due to herbicide exposure during service. The claims for a compensable rating for bilateral hearing loss and entitlement to TDIU prior to December 31, 2017 were denied.

The Board remands the claim for service connection of hypothyroidism to obtain an additional medical opinion regarding whether it was aggravated by the Veteran's service-connected fibromyalgia.

The Board remands the claims for service connection for various conditions due to toxic exposure during service, as required by the PACT Act.

The Board remands the claims for service connection for various conditions, including back cancer - tumor, bladder cancer, Bowen's disease, also claimed as carcinoma and skin condition, gastroenteritis, broken spine disc, also claimed as back pain and thoracic fracture (claimed as low back disorder), high blood pressure, hyperthyroidism, also claimed as thyroid condition, left hip condition, osteopenia/osteoporosis, peptic ulcer, also claimed as stomach ulcers, right foot vascular disorder, and sinusitis for further development.

The Board granted service connection for rheumatoid arthritis in all extremities, Sjogren's syndrome, a skin condition, and a thyroid condition. The evaluation for diabetes was denied, but the Veteran received an increased rating of 40 percent for peripheral neuropathy in both lower extremities from May 17, 2018, as well as TDIU.

The appeal for a higher rating for the thyroid condition is remanded due to an inadequate VA examination.

The Board granted service connection for hypothyroidism and stomach ulcer, but dismissed the claim for headaches.

The Board denied service connection for cirrhosis of the liver, chronic type III kidney disease, and hypothyroidism as there was no evidence to support a finding that the Veteran's conditions were related to his military service or exposure to herbicide agents.

The Board remands the claim for a thyroid condition, other than hypothyroidism, to obtain an additional etiology opinion that adequately addresses direct service connection and the PACT Act requirements.

The Board remands the claims for service connection for Graves' disease and a thyroid condition to correct pre-decisional duty to assist errors.

The appeal for service connection for hyperthyroidism was dismissed as the October 2022 rating decision did not constitute a final decision on the issue.

The Board granted an effective date of January 1, 2021 for the award of service connection for hypothyroidism and major depressive disorder as secondary to hypothyroidism. The claim for service connection for obstructive sleep apnea was remanded.